Stay updated on Safety of Single Dose UB-221 in Urticaria Clinical Trial

Sign up to get notified when there's something new on the Safety of Single Dose UB-221 in Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Single Dose UB-221 in Urticaria Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T03:24:54.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The web page has added new sections on Immunologic Factors, Physiological Effects of Drugs, and Antibodies, Monoclonal, enhancing its core content significantly.
    Difference
    0.5%
    Check dated 2025-04-23T18:59:50.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed information about a clinical study on UB-221, which included safety and efficacy evaluations, and the addition of terms related to chronic idiopathic urticaria and immunologic factors.
    Difference
    18%
    Check dated 2025-04-16T14:21:40.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T09:15:53.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The page has been updated to include new sections on Immunologic Factors, Physiological Effects of Drugs, and Antibodies, Monoclonal.
    Difference
    0.5%
    Check dated 2025-03-11T04:27:55.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-02-24T20:59:34.000Z thumbnail image

Stay in the know with updates to Safety of Single Dose UB-221 in Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Single Dose UB-221 in Urticaria Clinical Trial page.